Description

Cyclopropanecarboxamide, n-(2-Ethylpyrazolo[1,5-A]Pyridin-3-Yl)- (9Ci) is a high-purity, advanced pharmaceutical intermediate characterized by its unique fused heterocyclic structure incorporating pyrazolo[1,5-a]pyridine and cyclopropane moieties. This compound is of significant value in medicinal chemistry for the research and development of novel therapeutic agents, particularly due to its role as a key synthetic building block. It is primarily sought by R&D chemists and process development scientists in the pharmaceutical, biotechnology, and fine chemical industries engaged in creating new active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of novel drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used as a scaffold or building block for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• API Development: Employed in process chemistry for the scale-up and optimization of routes to potential Active Pharmaceutical Ingredients (APIs).
• Biochemical Tool Compound: May be utilized in biochemical assays to study enzyme inhibition or receptor modulation, aiding in target validation.
• Fine Chemical Synthesis: Acts as a specialized reagent for constructing complex molecular architectures in advanced organic synthesis.

Basic Information

Product Name	Cyclopropanecarboxamide, n-(2-Ethylpyrazolo[1,5-A]Pyridin-3-Yl)- (9Ci)
CAS No.	605673-04-9
Molecular Formula	C13H15N3O
Molecular Weight	229.28 g/mol
Synonyms	N-(2-Ethylpyrazolo[1,5-a]pyridin-3-yl)cyclopropanecarboxamide; 2-Ethyl-N-(2-ethylpyrazolo[1,5-a]pyridin-3-yl)cyclopropanecarboxamide (related); Cyclopropanecarboxamide, N-(2-ethylpyrazolo[1,5-a]pyridin-3-yl)-; 605673-04-9; UNII-7V8R8N6Q0N; 7V8R8N6Q0N; SCHEMBL23346895; DTXSID40631092
EINECS	Contact for details

Quality Control

Our Cyclopropanecarboxamide, n-(2-Ethylpyrazolo[1,5-A]Pyridin-3-Yl)- (9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) with detailed batch-specific data are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Individual impurity ≤ 1.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.